Related Experiment Videos
Craig Venter discusses life after the Human Genome Project. Interviewed by Rebecca Lawrence
1Craig Venter, President and CEO, Celera Genomics, 45 West Gude Drive, MD 20850, tel: +1 240 453 3500, fax: +1 240 453 3650, Rockville, USA
Drug Discovery Today
|February 13, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Delayed-onset facial nerve paresis following cochlear implantation: case report and literature review.
The Journal of laryngology and otology·2018
Controversies in the management of deep neck space infection in children: an evidence-based review.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2016
Analgesic drugs and the gut - a reciprocal relationship.
The journal of the Royal College of Physicians of Edinburgh·2016
Persistent Mycobacterium bovis-BCG is resistant to glutathione induced reductive stress killing.
Microbial pathogenesis·2016
The future of peptide ADMET prediction: Leveraging AI to unlock new possibilities.
Drug discovery today·2026
Dark proteome and emerging technologies for functional characterization and drug discovery.
Drug discovery today·2026
Pathway-driven target prioritisation in drug discovery.
Drug discovery today·2026
De-Escalation in United Kingdom Inpatient Mental Health Care: A Structured Critical Narrative Synthesis of People, Capability and Context.
International journal of mental health nursing·2026
Standards of Care for Assaulted Patients in Custody.
Journal of health care for the poor and underserved·2026
Differences in Early Tacrolimus Exposure in Kidney Transplant Recipients With and Without CYP3A5 Genotype-Guided Tacrolimus Dosing.
Clinical and translational science·2026
Coping Motives to Use Cannabis: Associations With Emotion Regulation and Gender Among System-Involved Youth.
Substance use & misuse·2026
Canadian news media reporting on involuntary substance use treatment and its evidence, 2020-2025: "At the cutting edge of debate, science and policy".
The International journal on drug policy·2026
A pilot study of BRAVE, a CBT intervention to reduce violence risk in early psychosis.
Cognitive behaviour therapist·2026